Life sciences
Grant writers who speak your science
Why life sciences applications fail
Strong science, weak proposal. The most common reasons we see: aims that aren't hypothesis-driven, no clear go/no-go milestones, missing power calculations, a regulatory pathway that reviewers can't follow, and a commercialization plan written as an afterthought.
We fix all five, in your own scientific voice, backed by writers who have sat on the research side of the bench.
Where we work
Therapeutics & drug discovery
Small molecule, biologics and cell & gene programs. Target validation through IND-enabling studies.
Diagnostics & devices
Assay development, point-of-care platforms, imaging and Class II/III device pathways.
Digital health & AI
Clinical decision support, remote monitoring and AI/ML models with a credible validation plan.
Research tools & bioprocessing
Instruments, reagents, organoids, lab automation and manufacturing scale-up.
Programs we target
NIH SBIR/STTR
Institute-specific topics with hard-science review panels. Phase I typically up to ~$300K, Phase II up to ~$2M.
NSF SBIR
Biotechnology is one of NSF's funded areas. Ideal for platform technologies that cut across health and industry.
ARPA-H, BARDA & DoD
Mission-driven health programs for high-risk, high-reward and defense-relevant medical innovation.
Let's fund your science
Book a free consultation with a grant writer who understands your therapeutic area or device pathway.